Skip to main content

Table 1 Primary characteristics of the cases and controls

From: Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease

Variants

Case (N = 509)

Control (N = 509)

p value

Age, years

62.16 ± 10.30

61.14 ± 9.02

0.094a

 > 60 (N, %)(N, %)

283 (55.6%)

284 (55.8%)

 

 ≤ 60 (N, %)

226 (44.4%)

225 (44.2%)

 

Gender

  

1.000b

Male (N, %)

335 (65.8%)

335 (65.8%)

 

Female (N, %)

174 (34.2%)

174 (34.2%)

 

TG (mmol/L)

1.62 ± 1.00

1.84 ± 1.46

0.006a

TC (mmol/L)

4.08 ± 1.08

4.76 ± 0.91

 < 0.001a

LDL (mmol/L)

3.83 ± 1.92

2.60 ± 0.73

0.157 a

HDL (mmol/L)

1.12 ± 0.26

1.17 ± 0.36

0.016 a

UA (μ mol/L)

300.90 ± 92.21

320.41 ± 79.40

0.001a

Urea

5.37 ± 2.14

5.15 ± 1.31

0.056a

RBC

4.82 ± 0.46

4.22 ± 0.97

 < 0.001a

WBC

10.75 ± 4.52

5.81 ± 1.51

 < 0.001a

Platelet (109/L)

183.04 ± 74.38

213.73 ± 59.60

 < 0.001a

HGB

129.73 ± 28.98

147.39 ± 16.33

 < 0.001a

Hypertension (N, %)

318 (62.5%)

  

Diabetes (N, %)

147 (28.9%)

  
  1. Numbers in bold mean statistical significance
  2. TG triglyceride; TC total cholesterol; LDL low-density lipoprotein; HDL high-density lipoprotein; UA uric acid; RBC red blood cells; WBC white blood cells; HGB hemoglobin
  3. p a and p b values were calculated by t-test and χ2 test, respectively